A plan to cook and live with

The nutrition you need.
The food you love.

An AI dietitian and AI chef delivering standard-of-care nutrition therapy, built for GPs to prescribe.

Clinician-founded
Live on iOS, Android and web
Seeking TGA and FDA approval

App Store Google Play Web app

Confidential. Not an offer of securities. See the important notice on the last page.

Try it

The problem

GPs refer patients for nutrition therapy.
Most never receive it.

Medicare claims within 2 years of a diabetes diagnosis

12,694

people aged 45+ newly diagnosed with diabetes (45 and Up Study, NSW).

Why the referral fails

01
Capped 5 Medicare-subsidised allied health visits a year, shared across all providers.
02
Hard to reach Doctors report access barriers between their patients and dietitians.
03
Stays on paper Turning advice into daily meals is left to the patient.

Sources: Aust J Prim Health, Apr 2026 (45 and Up Study); Services Australia, GP chronic condition management plans; Australian GP and physician interview study, 2020.

How it works

The GP prescribes.
WholeBite delivers the nutrition therapy.

1
GP prescribes Added to the patient’s chronic condition management plan.
2
Know the patient Diagnosis first, then the full profile a dietitian takes.
3
Prescribe Complete nutrition targets and a 7-day plan of 42 meals.
4
Support every day Logging, full nutrient tracking, Decode, Cook with what you have and an AI dietitian.

Today WholeBite is a wellness app. Clinical claims and GP prescribing follow TGA and FDA approval. Screen: WholeBite app, today view, Sep 2026.

WholeBite app, today view, September 2026

The product

Not just calories. Every nutrient, in every meal.

Weighed to the gramEvery ingredient is measured, for example 35 g oats, 20 g peanuts and 120 g milk.

39 nutrients per mealVitamins, minerals and essential fats such as omega-3s, as well as calories and macros.

98% of complete nutritionExample day from the app: the plan covers 98%, with every target met.

Explains every choice. Each meal shows its case, for example vitamin C to help absorb plant iron.

WholeBite nutrient breakdown, September 2026

Screens: WholeBite meal detail and nutrient breakdown, Sep 2026.

Evidence, not opinion

Every nutrition prescription follows the evidence, every time.

As a GP practice owner, I watched patients get referred for nutrition therapy. Most never went. Those who did got advice that depended on who they saw.

Arundhati Sinha, founder

	Usual referral	WholeBite
Reach	1 in 6 newly diagnosed see a dietitian through Medicare	On the patient’s phone the day it is prescribed
Consistency	Advice varies between practitioners	The same graded rules for every patient
Contact	A few visits a year	Every day, by chat
Meals	The patient turns advice into meals	Every meal planned, in the patient’s own cuisine
Scale	Limited by the workforce	Software, at app cost

Guideline-concordant by design: rule packs graded for evidence certainty (GRADE) across every condition it treats. Sources: Aust J Prim Health, Apr 2026; Moutou et al., J Hum Nutr Diet, 2021; US nutrition counsellor survey, 2024.

Traction

About 100 Android downloads a day, and 35% of trial starters pay.

~100a day. Android downloads, on average, since launch.

14 daysFree trial with every feature, then A$28 a month.

35%Of trial starters convert to paid (early cohort).

Live and working

Live on iOS, Android and the web
Paid acquisition running on Google Ads
AI cost down to A$5 per user a month
Grocery delivery API integration under way

What we report next

Week-2 return rate
Month-3 paid retention
Cost per install and per payer
iOS and web numbers

Company data, September 2026. The download figure is Android only. The 35% is trial-to-paid in our first cohort of trial starters.

Market

Start with diabetes on GP care plans. Then every diet-related condition.

A$4.4bnTAM. 13m Australian adults with overweight or obesity × A$336 a year.

A$280mSAM. ~830k adults with diabetes on a GP care plan × A$336 a year.

A$14mSOM. Illustration: 5% of the beachhead, ~42k patients.

SAM = AIHW’s 1.3m adults with diabetes × the 64% of patients with diabetes who used a GP care plan item (AIHW, 2016 data). Consumer price only; conditions overlap.

The GP channel

4m Australians used a GP chronic disease management plan in 2020–21, 16% of the population.

Worldwide

2.5bn adults overweight, 1.4bn with hypertension, 589m with diabetes.

Sources: AIHW (2021, 2022, 2026); ABS 2022; WHO 2025; IDF 2024. Full list in Appendices E and F.

Revenue streams

Three ways to earn from every plan: subscription, groceries and ready meals.

Live with paying users

Subscription

A$28 a month with a 14-day free trial. Modelled at A$16.64 per subscriber after GST, store fees and AI costs.

A$16.64

modelled, per subscriber per month

API integration under way

Grocery delivery

Each week’s plan becomes a personalised grocery order, delivered fresh on the day the patient chooses. We earn on every basket.

A$11.8bn

online grocery sales in Australia, 2026

Next

Ready meals

Meal-prep partners cook the plan and deliver finished meals every two days. We earn on every meal.

A$1.1bn + A$1.9bn

meal kits + prepared meals in Australia

Illustration: households spend about A$237 a week on food and drink. Every 1% we earn on that basket adds about A$10 a month per household. Target partners: supermarkets such as Coles and Woolworths, and meal-kit and meal-prep companies such as HelloFresh. Sources: IBISWorld (online grocery 2026; meal kits 2023–24; prepared meals 2024–25); ABS Household Expenditure Survey 2015–16, latest, not inflation-adjusted.

Who pays

Patients pay from day one. Insurers and governments after approval.

The lesson: Better Therapeutics and Pear Therapeutics won FDA De Novo authorisation, then ran out of money waiting for reimbursement. WholeBite does not depend on it.

Now

Patients

A GP recommends WholeBite and the patient subscribes at A$28 a month. Grocery and meal revenue sits on top. No payer needed.

Next

Private health insurers

Australian insurers have been able to fund chronic disease management programs since 2007. Target: an insurer-funded program for members.

After approval

Governments and US payers

US: CMS’s ACCESS model pays for outcomes in diabetes, hypertension, dyslipidaemia and obesity, and FDA’s TEMPO pilot allows early use within it. Australia: MBS listing through MSAC.

Our pivotal study will measure what payers buy: HbA1c, weight and health-care costs. Sources: MedTech Dive and Fierce Biotech (Mar 2024); Australian Health Review (2019); FDA TEMPO pilot and CMS ACCESS model (Dec 2025). See Appendix F.

Regulatory pathway

Approval turns WholeBite into a medical device GPs can prescribe.

Today
Wellness app
Live on iOS, Android and web. No medical claims.
Australia · TGA
Likely Class IIb
Software that recommends treatment directly to the user, for a serious condition. ARTG inclusion is required to supply it with medical claims.
United States · FDA
De Novo authorisation
The route AspyreRx took in 2023 to become a prescription digital therapy for type 2 diabetes.

One evidence package, two markets: the TGA accepts FDA De Novo decisions, with an MDSAP certificate, for Class IIa and IIb devices. Sources: TGA, classifying software-based medical devices (rule 4.5); TGA, using comparable overseas regulators; Better Therapeutics, Jul 2023. Final class to be confirmed.

Competition

Payers already fund nutrition care. Others scale with dietitians; we use software.

Who	What they do
Calorie trackers	Log what people have already eaten
Noom	Behaviour-change coaching for weight loss
Nourish (US)	Insurance-covered telehealth dietitians; raised US$70m in 2025
Foodsmart (US)	Telenutrition and food benefits for health plans; US$200m+ invested in 2024
EatLove PRO	Condition-aware meal plans for health professionals
Retain	An AI dietitian with personalised plans
WholeBite	Standard-of-care nutrition therapy + food from your own culture + daily support, at software cost. Seeking TGA and FDA approval.

Nourish and Foodsmart prove the demand but scale with dietitian headcount. WholeBite runs on software at about A$5 a user a month. Competitor details from company websites and funding announcements (Nourish, Apr 2025; Foodsmart, Jun 2024). See Appendix F.

Versus the most-used apps

The most-used apps count calories. WholeBite is built to deliver nutrition therapy.

	MyFitnessPal	Yazio	Lifesum	Lose It!	WholeBite
Users	280m+ members	100m+	65m	57m+	New in 2026
Last known value	Sold for US$345m (2020)	Private, not disclosed	Private; SEK 220m revenue (2023/24)	Ziff Davis deal, 2022 (price private)	A$18m post-money, proposed
Starts from	Weight and fitness goals	Calorie goal and fasting	Goals and diet style	Weight-loss goals	Your diagnosis and full dietetic profile
Nutrition	Tracks calories and macros	Tracks calories and macros	Tracks calories and macros	Tracks calories; macros in Premium	Plans 39 nutrients into every meal
Meal plans	Recipe planner (Premium+)	Meal planning tools and recipes	Diet-style plans with grocery lists	Per-meal calorie targets	42 meals a week in your own cuisine
AI photo logging	Yes (Premium)	Yes	Yes	Yes (Premium)	Yes
Medical pathway	Wellness app	Wellness app	Wellness app	Wellness app	TGA and FDA approval sought

They prove the demand: over 500m sign-ups between them. None starts from a diagnosis or leads to GP prescribing. Exits happen: Ziff Davis bought Lose It! (2022); MyFitnessPal bought Cal AI (2026). Users are company-stated totals, Sep 2026. Values are the last publicly disclosed figures; none of these companies publishes a current valuation. See Appendix G.

Intellectual property

Our own medical AI, trained in-house. Not a wrapper on someone else’s chatbot.

A fine-tuned nutrition model

A small LLM trained on guidelines, protocols and food and nutrition data. It runs the pathway: analysis, prescription and coaching.

Wired into our food database

The model works directly on 82,000 foods and 39 nutrients per meal, so answers are fast and consistent.

Guidelines as code

GRADE-graded rule packs for diabetes, heart failure, PCOS and weight. Code checks every number.

A proven medical AI pipeline

Built by Arundhati Health Services, the company behind DIAGNIFY: in-house models for diagnosis, ECG reading and image analysis.

What a copycat would need

1
A medical fine-tuning pipeline. Ours was built and proven on DIAGNIFY.
2
A curated clinical training set: guidelines, protocols and food data.
3
A nutrient database wired into the model, with code that checks it.
4
Evidence-graded rule packs for every condition.
5
TGA and FDA clearance with clinical evidence. This round funds ours.

A competitor can rent a chatbot. It cannot rent our model, our data or our clinical rules. Protection: model weights, training data and database held in-house as trade secrets; copyright in code; WholeBite trade mark clearance under way.

Defensibility

A moat before approval, and a much deeper one after it.

Before approval

·
A warm GP channel 50 doctors across 7 Brisbane clinics already pilot DIAGNIFY Intake, our sister product.
·
A$5 a month to serve Dietitian-led services scale with headcount; WholeBite scales on software.
·
Personal food data Every swap, rating and favourite makes the next plan fit better.

After approval

·
TGA and FDA clearance A certified quality system and regulator decisions take competitors years to replicate.
·
Clinical evidence Pivotal study results that GPs and payers can rely on.
·
The GP channel Prescribing inside chronic condition management plans.

Standard-of-care output, every time: the same guideline targets and checks for every patient. User data is consented and user-controlled. Clinical rules change only through expert review.

Team

A clinician founder and an in-house AI team. Advisers and hires take it through approval.

Founder

Arundhati Sinha

Master’s-qualified in dentistry; former dental prosthetist
Previous owner of a GP practice
Founder of DIAGNIFY.AI: in-house medical AI for diagnosis, ECG and imaging
Trained WholeBite’s own nutrition model
Legal background, applied to compliance
Exercise prescription app in development

Who builds it

An in-house team at Arundhati Health Services, the company behind DIAGNIFY.

AI engineerData scientistDeveloperFull-stack developer

Model, training data and database are built and held in-house.

Advisory board, being appointed

Dietitian (APD)EndocrinologistRegulatory expert (SaMD)

First hires from this round

1 · Regulatory and quality lead
2 · Clinical evidence lead
3 · Nutrition and safety engineer

The ask

A$4.5m

Raising A$4.5m to take WholeBite through TGA and FDA approval.

Equity round. 18–24 months of runway. Outcome: FDA De Novo and TGA applications filed, clinical evidence in hand, subscription revenue growing and grocery revenue started. The natural point for the next round.

Approval is the value inflection
It turns a wellness app into a medical device GPs can prescribe, with medical claims and payer contracts to follow.
The product is already built
Live on iOS, Android and web. This money buys evidence and approval, not a build from scratch.
It builds the moat
Clinical evidence, a certified quality system and regulator decisions take competitors years to copy.

Non-dilutive funding on top: the R&D Tax Incentive (43.5% refundable offset) and MRFF-backed grants such as MTPConnect’s TTRA (up to A$1m).

Proposed terms

A$4.5m at a A$13.5m pre-money valuation. What each cheque buys.

The round

Raise	A$4.5m
Pre-money valuation	A$13.5m
Post-money valuation	A$18m
Investors’ combined share	25%
Instrument	Priced equity round
Runway	18–24 months

What each cheque buys

Investment	Share at close
A$50,000	0.28%
A$100,000	0.56%
A$250,000	1.39%
A$500,000	2.78%
A$1,000,000	5.56%
A$4,500,000 (the whole round)	25.00%

Share at close = investment ÷ A$18m post-money valuation. Why this price: a live product with paying users, our own medical AI and a defined TGA and FDA pathway. Proposed terms, subject to due diligence and final documents. Next round after the FDA De Novo and TGA submissions.

Use of funds

Where the A$4.5m goes: evidence, approval and the team to deliver it.

A$4.5m equity round.

Clinical evidenceFeasibility pilot and pivotal study against usual care (HbA1c), sized with the FDA at pre-submission.
A$1.5m · 33%
TeamRegulatory, clinical evidence, nutrition safety and software hires for 18 months.
A$1.35m · 30%
Regulatory and qualityISO 13485 with MDSAP, IEC 62304, risk, cybersecurity and usability files, FDA De Novo and TGA fees.
A$0.75m · 17%
Growth and partnershipsConsumer acquisition, grocery and meal-prep integrations, real-world evidence.
A$0.6m · 13%
ContingencyBuffer for regulator questions and study timing.
A$0.3m · 7%

Milestones: months 0–6 quality system and FDA pre-submission; 6–15 clinical study; 15–24 FDA De Novo and TGA submissions. Budget estimates for an 18-month plan. FDA De Novo small-business fee US$47,755 (MDUFA FY2027). Full milestones in the appendix.

Investor discussion · September 2026

Make the right food the easiest daily choice.

Evidence-based nutrition therapy that GPs can prescribe, delivered by AI. Free 14-day trial. In the PDF, tap a code or link to open it. On the web, use the links.

App Store Google Play wholebite.ai · no download needed

hello@wholebite.ai

Everyday breakfast

Appendix A · Unit economics (modelled)

After GST, store fees and AI costs, each subscriber leaves A$16.64 a month.

Price per month (incl. GST)	A$28.00
Less GST (10%) and store fee (15%)	A$6.36
Received per subscriber	A$21.64
Less AI and running cost (current)	A$5.00
Left per subscriber, per month	A$16.64

Assumes app-store sales at a 15% fee. Excludes marketing, team costs, refunds, and grocery or meal revenue. No lifetime value until churn is measured.

Appendix B · Safety design

The AI is creative with food. The numbers are checked by code.

Five checks between a request and a plate, each to be independently validated.

1
Check fit Consent, allergies, goals, health conditions and exclusions.
2
Set targets NHMRC nutrient reference values and reviewed condition rules.
3
Create recipes The AI chef personalises cuisine and flavour inside those limits.
4
Recheck numbers Code recalculates nutrients, limits, allergens and swaps from food data.
5
Confirm and log The user approves changes. High-risk cases go to a clinician.

Wellness app today: no diagnosis, no medication changes. Medical claims only after TGA and FDA approval. Sources: NHMRC Nutrient Reference Values; FSANZ AUSNUT 2023; TGA guidance on coaching software exclusions (Mar 2026).

Appendix C · Validation plan

How we will prove it works. Three stages, each answering a different question.

Technical testing

Are the numbers right? Test profiles, independent nutrient recalculation, allergy and unit checks, recipe-to-day consistency.

Feasibility pilot

Will people use it? Independently reviewed protocol: plan use, taste, effort, retention, costs and safety events.

Clinical study

Does it improve health? Condition-specific study for TGA and FDA, with outcomes such as HbA1c chosen by the clinical team.

Pilot and study protocols set eligibility, sample size, comparison group, main outcome and safety reporting in advance.

Appendix · How the AI works

One in-house model, wired to our data and the guidelines.

Patient profile

Diagnosis and conditions. Allergies and food rules. Goals and targets. Cuisines and liked foods. Kitchen, household and grocery day.

WholeBite model

Our fine-tuned LLM. AI dietitian. AI chef. Analysis, prescription and coaching.

Food database and rule packs

82,000 foods, 39 nutrients. GRADE-graded, expert-reviewed.

Code checks

Nutrient maths from food data. Floors and caps for each nutrient. Allergens and exclusions. No repeats within a week.

The patient gets a nutrition prescription, a 7-day plan of 42 meals, daily tracking and coaching, and a grocery list for the week.

The model runs the pathway. Code checks every number. Clinical rules change only through expert review.

Appendix · Product: know the patient

Diagnosis first. Then everything a dietitian needs before prescribing.

·
Diagnosis and health Diabetes, hypertension, high cholesterol, obesity, coeliac disease and more.
·
Food allergies Every meal is built around them and checked ingredient by ingredient.
·
Body and goals Age, sex, BMI (calculated) and the goals of therapy.
·
Kitchen and routine Beginner to batch cook, how many they cook for, grocery day.
·
Absolute rules Religious or personal rules, such as no beef, no pork or fasting days.
·
Where they live Country of residence, country of origin and time zone.
·
Food they love Cuisines first: 31 to choose from, several at once for variety. Then favourites in each food group.

Indian · PunjabiIndian · SouthJapaneseVietnameseMediterraneanModern Australian+25 more FruitVegetablesLegumesGrainsNutsMeatDairyHerbsDrinks

Screen: WholeBite profile, cuisine picker, Sep 2026.

WholeBite cuisine picker, September 2026

Appendix · Product: prescribe

The profile produces a nutrition prescription and a 7-day meal plan.

1
Personal nutrition prescription Daily targets for energy, protein, fats, carbohydrates, vitamins and minerals, set for the condition. Built so that removing a food does not leave a nutrient gap.
2
A 7-day plan of 42 meals 3 main meals and 3 snacks a day, designed as medical nutrition therapy, in the diet style, cuisines and foods the patient chose.

MTWTFSSPrep stepsGrocery listPersonal cookbookSwap any mealShare the week

Screen: WholeBite meal planner, Sep 2026.

Appendix · Product: logging

Logging takes seconds. Two features make it fun.

Log any way

From the plan one tap: I ate this

Camera snap the plate

Voice say what you ate

Search 82,000 foods

Decode

Scan any food or label to get a score, its additives and how processed it is.

Cook with what you have

Photograph what is in the kitchen and get a meal that fits today’s nutrition targets.

Screen: WholeBite meal logging, Sep 2026.

Appendix · Product: daily tracking

Every nutrient, tracked every day, with an AI dietitian on call.

·
A daily score One number for the day, plus how many targets are met, close or short.
·
Every nutrient Calories, food groups, macros, 11 vitamins, 11 minerals, 7 fats including omega-3s, fibre, salt, sugar and plant variety.
·
Shows what is short For example omega-3s (EPA and DHA), choline or potassium, so the next meals can close the gap.
·
AI dietitian on call Not a general chatbot. Our own model, trained on nutrition data and guidelines, with the guideline and research library behind it. It sees the patient’s profile, plan and log.

Everything the patient does feeds into next week’s plan. Screens: WholeBite daily nutrition score, Sep 2026.

WholeBite daily nutrition score, September 2026

Appendix · Why people stay

People stick with food they love.

WholeBite keeps familiar dishes and adjusts what goes into them to hit each person’s targets.

Appendix · Channel roadmap

Subscription model first. GP prescriptions next.

Consumer subscription: A$28 per month, 14-day free trial. Modelled: A$16.64 per subscriber each month after GST, store fees and A$5 AI cost.

Now

Consumer app

Subscriptions through the app stores and the web.

Next

GP-prescribed

In Australia after TGA approval, within chronic condition management plans.

Later

US and payers

US launch after FDA authorisation, then insurer and employer contracts.

The consumer app keeps growing while approval is in progress.

Appendix · Market by condition

One engine for every diet-related condition. Two in three Australian adults have at least one.

13madults with overweight or obesityAIHW, 2022

7.2madults with high blood pressureAIHW, 2022 data

5.6madults with high cholesterolABS, latest measured, 2011–12

~30%of adults with metabolic syndromeVictor Chang Institute

1.3madults with diabetesAIHW, 2022–24

1 in 70Australians with coeliac disease, 80% undiagnosedCoeliac Australia

2–4%of adults with a food allergy, 5–10% of childrenASCIA

+ moreInflammatory conditions, nutrient deficiencies and moreSame engine, same standard

Beachhead: metabolic health in Australia. Then every condition the engine covers. Then global. Conditions overlap, so these figures are not added together. Full sources in Appendix E.

Appendix · Global market

A billion-person problem worldwide, with a simple path to revenue.

2.5bnadults overweight, 890m of them with obesity. WHO, 2022 data.

1.4bnadults aged 30–79 with hypertension. WHO, 2024 data.

589madults with diabetes. IDF, 2024 estimate.

Australia: total addressable market

A$4.4bn

a year. 13m adults with overweight or obesity × A$336 a year (A$28 a month). Consumer price only, before any prescribed or payer-funded pricing.

A$3.36ma year at 10,000 subscribers

A$33.6ma year at 100,000 subscribers, under 1% of the 13m

Gross billings before tax, fees and churn. Scenarios, not forecasts. Sources: WHO fact sheets on obesity and hypertension (2025); IDF Diabetes Atlas, 11th edition; AIHW. Full list in Appendix E.

Appendix · Milestones

What the round delivers, stage by stage.

18–24 months from close to the FDA De Novo and TGA submissions.

Months 0–6
Medical-grade build
- ISO 13485 quality system
- IEC 62304 software process
- Risk file and FDA pre-submission
Months 6–15
Clinical evidence
- Nutrient accuracy validation
- Study vs usual care (e.g. HbA1c)
- Ethics approval and independent oversight
Months 15–24
Approval
- FDA De Novo submission
- TGA ARTG application
- GP launch, then new indications

The consumer app keeps growing in parallel and adds real-world evidence.

Appendix D · Sources

Sources

From referral to reality: allied health use after a diabetes diagnosis — Australian Journal of Primary Health, Apr 2026 (45 and Up Study).
Allied health referrals for GP chronic condition management plans — Services Australia. Accessed Sep 2026.
Doctors identify barriers to dietitian access in type 2 diabetes — Australian GP and physician interview study, 2020.
Dietitians’ advice on dietary patterns for type 2 diabetes — Moutou et al., J Hum Nutr Diet, 2021.
Nutrition counsellors’ recommended eating patterns for type 2 diabetes — US survey study, 2024.
Increasing vegetable intake by emphasizing tasty attributes — Turnwald et al., Psychological Science, 2019.
IDF Diabetes Atlas, 11th edition — International Diabetes Federation. 2024 estimates.
Diabetes: Australian facts — Australian Institute of Health and Welfare. Updated 27 May 2026.
Classifying software-based medical devices — Therapeutic Goods Administration. Accessed Sep 2026.
Using assessments from comparable overseas regulators — Therapeutic Goods Administration. Accessed Sep 2026.
FDA authorises AspyreRx for type 2 diabetes (De Novo) — Better Therapeutics announcement, 10 Jul 2023.
Behavioural change or coaching software exclusion — Therapeutic Goods Administration. 16 Mar 2026.
Nutrient Reference Values — NHMRC / Eat for Health. Accessed 22 Sep 2026.
AUSNUT 2023 — Food Standards Australia New Zealand. 10 Sep 2025.
WholeBite on the App Store. Also on Google Play and at wholebite.ai.
Competitor websites: EatLove PRO, AnyDish, Retain. Accessed 22 Sep 2026.

Research current to 24 Sep 2026. Click a title to open the source.

Appendix E · Market and revenue sources

Market and revenue sources

Waist circumference and BMI, 2022 — Australian Bureau of Statistics. 65.8% of adults overweight or obese.
Overweight and obesity — AIHW web report, Jun 2024. About 13 million adults in 2022.
Hypertension in Australia — AIHW, May 2026: 39% of adults, about 7.2 million. Reported by RACGP newsGP.
Australian Health Survey: biomedical results, 2011–12 — Australian Bureau of Statistics. 5.6 million adults with high total cholesterol.
Metabolic syndrome — Victor Chang Cardiac Research Institute, Jul 2023. Around 30% of adults.
Coeliac Awareness Week 2026 — Coeliac Australia. 1 in 70 Australians, about 80% undiagnosed.
Food allergy: fast facts — ASCIA, 2023. 2–4% of adults and 5–10% of children.
Obesity and overweight — WHO fact sheet, Dec 2025. 2.5 billion adults overweight in 2022.
Hypertension — WHO fact sheet, Sep 2025. 1.4 billion adults aged 30–79 in 2024.
Online grocery sales in Australia — IBISWorld. A$11.8bn in 2026.
Meal kit delivery services in Australia — IBISWorld. About A$1.1bn in 2023–24.
Prepared meal manufacturing in Australia — IBISWorld. About A$1.9bn in 2024–25.
Household Expenditure Survey, 2015–16 — Australian Bureau of Statistics. A$237 a week on food and non-alcoholic drinks.

Research current to 24 Sep 2026. Click a title to open the source.

Appendix F · Payer, funding and competitor sources

Payer, funding and competitor sources

Better Therapeutics lays off staff, considers winding down — MedTech Dive, Mar 2024.
Digital diabetes app maker Better Therapeutics shutters operations — Fierce Biotech, Mar 2024. Includes Pear’s Apr 2023 bankruptcy.
Use of Medicare chronic disease management items — AIHW via APO. 4 million people used a GP plan in 2020–21; 64% of patients with diabetes.
Private health insurance chronic disease management programs — Australian Health Review, 2019. Insurers able to fund CDMPs since 2007.
TEMPO for Digital Health Devices Pilot — U.S. FDA, with the CMS ACCESS model. Accessed Sep 2026.
FDA opens a CMS-linked side door (ACCESS and TEMPO) — Hogan Lovells, Dec 2025.
TTRA funding round for heart disease and diabetes devices — MTPConnect (MRFF), Feb 2026. Up to A$1m non-dilutive.
Nourish lands US$70m for AI-powered nutrition care — Fitt Insider, Apr 2025.
Foodsmart lands US$200m for telenutrition — Athletech News, Jun 2024.

Research current to 24 Sep 2026. Click a title to open the source.

Appendix G · Consumer app and valuation sources

Consumer app and valuation sources

MyFitnessPal debuts its 2026 Winter Release — GlobeNewswire, Feb 2026. 280m+ members; Premium and Premium+ features.
MyFitnessPal has acquired Cal AI, the viral calorie app built by teens — TechCrunch, Mar 2026. 15m+ downloads and US$30m+ annual revenue.
Lose It! Calorie Counter — Apple App Store listing. Premium features: photo and voice logging, meal targets.
Under Armour to sell MyFitnessPal to Francisco Partners — SEC filing (8-K), Oct 2020. Transaction value US$345m, including earn-outs.
Under Armour agrees MyFitnessPal sale for US$345m — SportsPro, Nov 2020. Under Armour paid US$475m for it in 2015.
YAZIO: AI Calorie Tracker — Apple App Store listing. 100m+ users; meal planning tools and recipes.
Lifesum: AI Calorie Counter — Apple App Store listing. 65m users; diet-style meal plans with grocery lists.
Calorie Counter by Lose It! — Google Play listing. 57m+ users.
Lifesum attracts interest from potential investors — NKP M&A Insights. Net sales SEK 220m and EBITDA SEK 24.4m for 2023/24.
Ziff Davis completes acquisition of Lose It! — PrivSource deal record. Completed Q2 2022; terms not disclosed.

Research current to 25 Sep 2026. User numbers are company-stated totals; values are the last public figures. Click a title to open the source.

Important notice

Confidential. Prepared by WholeBite for discussion with prospective investors. Please do not forward it without our consent.

Not an offer. This is not a prospectus or other disclosure document under the Corporations Act 2001 (Cth), and it is not an offer or invitation to buy securities.

Wholesale investors only. Any offer will be made only to people who do not need disclosure under section 708 of the Corporations Act, such as sophisticated and professional investors.

Not advice. It does not take into account your objectives, financial situation or needs. Get your own financial, legal and tax advice.

Estimates. Market sizes, modelled unit economics, budgets, valuations and plans are forward-looking. They rest on assumptions, may change and are not promises of future results.

Third-party data. Competitor and market figures come from public sources that we have not independently verified.

Regulatory status. WholeBite is a wellness app today. It has not been approved by the TGA or FDA and makes no medical claims.

The nutrition you need.The food you love.

GPs refer patients for nutrition therapy.Most never receive it.

The GP prescribes.WholeBite delivers the nutrition therapy.

Not just calories. Every nutrient, in every meal.

Every nutrition prescription follows the evidence, every time.

About 100 Android downloads a day, and 35% of trial starters pay.

Live and working

What we report next

Start with diabetes on GP care plans. Then every diet-related condition.

Three ways to earn from every plan: subscription, groceries and ready meals.

Subscription

Grocery delivery

Ready meals

Patients pay from day one. Insurers and governments after approval.

Patients

Private health insurers

Governments and US payers

Approval turns WholeBite into a medical device GPs can prescribe.

Wellness app

Likely Class IIb

De Novo authorisation

Payers already fund nutrition care. Others scale with dietitians; we use software.

The most-used apps count calories. WholeBite is built to deliver nutrition therapy.

Our own medical AI, trained in-house. Not a wrapper on someone else’s chatbot.

What a copycat would need

A moat before approval, and a much deeper one after it.

Before approval

After approval

A clinician founder and an in-house AI team. Advisers and hires take it through approval.

Raising A$4.5m to take WholeBite through TGA and FDA approval.

Approval is the value inflection

The product is already built

It builds the moat

A$4.5m at a A$13.5m pre-money valuation. What each cheque buys.

The round

What each cheque buys

Where the A$4.5m goes: evidence, approval and the team to deliver it.

Make the right food the easiest daily choice.

After GST, store fees and AI costs, each subscriber leaves A$16.64 a month.

The AI is creative with food. The numbers are checked by code.

How we will prove it works. Three stages, each answering a different question.

Technical testing

Feasibility pilot

Clinical study

One in-house model, wired to our data and the guidelines.

Diagnosis first. Then everything a dietitian needs before prescribing.

The profile produces a nutrition prescription and a 7-day meal plan.

Logging takes seconds. Two features make it fun.

Every nutrient, tracked every day, with an AI dietitian on call.

People stick with food they love.

Subscription model first. GP prescriptions next.

Consumer app

GP-prescribed

US and payers

One engine for every diet-related condition. Two in three Australian adults have at least one.

A billion-person problem worldwide, with a simple path to revenue.

What the round delivers, stage by stage.

Medical-grade build

Clinical evidence

Approval

Sources

Market and revenue sources

Payer, funding and competitor sources

Consumer app and valuation sources

Important notice

The nutrition you need.
The food you love.

GPs refer patients for nutrition therapy.
Most never receive it.

The GP prescribes.
WholeBite delivers the nutrition therapy.